ATE498391T1 - Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess. - Google Patents

Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess.

Info

Publication number
ATE498391T1
ATE498391T1 AT06018423T AT06018423T ATE498391T1 AT E498391 T1 ATE498391 T1 AT E498391T1 AT 06018423 T AT06018423 T AT 06018423T AT 06018423 T AT06018423 T AT 06018423T AT E498391 T1 ATE498391 T1 AT E498391T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
preparation process
liquid composition
bone diseases
Prior art date
Application number
AT06018423T
Other languages
English (en)
Inventor
Liliana Elizabeth Diaz
Original Assignee
Gador Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador Sa filed Critical Gador Sa
Application granted granted Critical
Publication of ATE498391T1 publication Critical patent/ATE498391T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06018423T 2006-09-04 2006-09-04 Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess. ATE498391T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06018423A EP1894557B1 (de) 2006-09-04 2006-09-04 Flüssige Zusammensetzung für die Behandlung und/oder Verhinderung von verschiedenen metabolischen Knochenkrankheiten, Verwendung davon und Vorbereitungsprozess.

Publications (1)

Publication Number Publication Date
ATE498391T1 true ATE498391T1 (de) 2011-03-15

Family

ID=37440291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06018423T ATE498391T1 (de) 2006-09-04 2006-09-04 Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess.

Country Status (14)

Country Link
EP (1) EP1894557B1 (de)
AR (1) AR062596A1 (de)
AT (1) ATE498391T1 (de)
AU (1) AU2007294261B2 (de)
CL (1) CL2007002514A1 (de)
CY (1) CY1111202T1 (de)
DE (1) DE602006020137D1 (de)
DK (1) DK1894557T3 (de)
ES (1) ES2361333T3 (de)
MY (1) MY148248A (de)
PL (1) PL1894557T3 (de)
PT (1) PT1894557E (de)
SI (1) SI1894557T1 (de)
WO (1) WO2008028547A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191414B (zh) * 2013-03-29 2014-10-22 武汉中博绿亚生物科技有限公司 一种宠物快速吸收的液体钙及其制备方法
CN116616449A (zh) * 2023-06-05 2023-08-22 浙江索契壹营养科技有限公司 一种酸性抗菌体系稳定承载高钙和维生素d的饮液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof

Also Published As

Publication number Publication date
AU2007294261A1 (en) 2008-03-13
MY148248A (en) 2013-03-29
WO2008028547A1 (en) 2008-03-13
DE602006020137D1 (de) 2011-03-31
AR062596A1 (es) 2008-11-19
EP1894557B1 (de) 2011-02-16
PL1894557T3 (pl) 2011-07-29
DK1894557T3 (da) 2011-05-30
EP1894557A1 (de) 2008-03-05
CY1111202T1 (el) 2015-06-11
SI1894557T1 (sl) 2011-04-29
ES2361333T3 (es) 2011-06-16
AU2007294261B2 (en) 2012-09-06
PT1894557E (pt) 2011-03-02
CL2007002514A1 (es) 2008-01-11

Similar Documents

Publication Publication Date Title
EP2985281A3 (de) Isoindolin-verbindungen zur behandlung von krebs
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP2282737A4 (de) Zusammensetzungen und verfahren zur behandlung von parodontalerkrankung mit clonidin, sulindac und/oder fluocinolon
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
EP1991055A4 (de) Formulierungen, die ein nichtoxidatives biozid und eine quelle von aktivem halogen enthalten, und ihre verwendung bei der behandlung von wasser
EP1916964A4 (de) Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
DE602008000403D1 (de) Behandlung von medizinischen Implantaten, die kalkbeständig sind
EP2415476A4 (de) Zusammensetzung zur vorbeugung und/oder behandlung von hautkrankheiten
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
ATE446754T1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
EP1905452A4 (de) Wirkstoff zur prävention oder behandlung von glaukomen
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EP1924269A4 (de) Vegetationswasser-zusammensetzung zur behandlung von entzündlichen hautkrankheiten
FR2900819B1 (fr) Compose de type bis-uree, composition le comprenant, utilisation et procede de traitement cosmetique
EP2716285A3 (de) Neues Verfahren zur Identifikation von Komponenten zur Behandlung und/oder Verhinderung von mit Erkrankungen zusammenhängendem Knochenschwund
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
DE602006006950D1 (de) Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis
ATE498391T1 (de) Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess.
DE602007008759D1 (de) Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1894557

Country of ref document: EP